Multivessel coronary artery disease (MVCAD) is found in approximately 50% of patients with
acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) …

Contrast-associated acute kidney injury (CA-AKI) is an impairment of renal function, which
occurs within days of intravascular administration of iodinated contrast media. Taking into …

Background Acute kidney injury (AKI) is prevalent in hospitalized patients with traumatic
brain injury (TBI), and increases the risk of poor outcomes. We designed this study to …

Background Increased uric acid (UA) levels have been reported to be associated with poor
clinical outcomes in several conditions. However, the prognostic value of UA in patients with …

Background The serum uric acid/albumin ratio (sUAR), a novel inflammatory marker,
effectively predicts acute kidney injury (AKI) and cardiovascular outcomes. However …

Abstract Background and Objective: Acute kidney injury (AKI) is a common complication
associated with adverse outcomes among patients with ST-segment elevation myocardial …

Abstract Background In March 2022, a COVID-19 outbreak disrupted the global supply of
iodine contrast media (ICM). Healthcare systems implemented contrast-saving strategies to …

Background The prognostic significance of serum uric acid (SUA) in individuals who have
experienced myocardial infarction (MI) remains a subject of academic debate. Thus, the aim …

Background This study assessed the predictive value of uric acid (UA) for contrast-induced
acute kidney injury (CI-AKI) in patients with type 2 diabetes mellitus (T2DM) who underwent …

Elevated serum uric acid (SUA) levels have been associated with several cardiovascular
risk factors and the progression of coronary artery disease. In the setting of acute myocardial …